ANTIBODY-DRUG CONJUGATES
Clinical trials for ANTIBODY-DRUG CONJUGATES explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY-DRUG CONJUGATES trials appear
Sign up with your email to follow new studies for ANTIBODY-DRUG CONJUGATES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug offers hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing an experimental drug called Trastuzumab Rezetecan for people with advanced HER2-positive cancers that have stopped responding to standard treatments. The trial will enroll 90 participants with specific rare or hard-to-treat tumors to see if the drug can shri…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Simple stockings could shield cancer patients from Treatment's painful side effect
Symptom relief Recruiting nowThis study is testing if wearing a medical compression stocking on one foot during cancer treatment can prevent nerve damage, a common and painful side effect. The trial involves 58 patients with advanced cancers who are receiving a specific type of targeted drug therapy. Researc…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: NA • Sponsor: Sheng Zhang • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC